RAPT Therapeutics (RAPT) Other Non-Current Assets (2020 - 2024)
Historic Other Non-Current Assets for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $389000.0.
- Therapeutics' Other Non-Current Assets fell 9075.35% to $389000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $389000.0, marking a year-over-year decrease of 9075.35%. This contributed to the annual value of $3.9 million for FY2023, which is 408.82% down from last year.
- Per Therapeutics' latest filing, its Other Non-Current Assets stood at $389000.0 for Q3 2024, which was down 9075.35% from $447000.0 recorded in Q2 2024.
- In the past 5 years, Therapeutics' Other Non-Current Assets registered a high of $4.3 million during Q2 2023, and its lowest value of $389000.0 during Q1 2020.
- Over the past 5 years, Therapeutics' median Other Non-Current Assets value was $447000.0 (recorded in 2024), while the average stood at $1.9 million.
- Per our database at Business Quant, Therapeutics' Other Non-Current Assets surged by 69460.15% in 2022 and then tumbled by 9075.35% in 2024.
- Over the past 5 years, Therapeutics' Other Non-Current Assets (Quarter) stood at $389000.0 in 2020, then skyrocketed by 651.16% to $2.9 million in 2021, then surged by 38.12% to $4.0 million in 2022, then decreased by 4.09% to $3.9 million in 2023, then plummeted by 89.95% to $389000.0 in 2024.
- Its Other Non-Current Assets stands at $389000.0 for Q3 2024, versus $447000.0 for Q2 2024 and $447000.0 for Q1 2024.